Cargando…
Defining the Earliest Pathological Changes of Alzheimer’s Disease
The prospects for effectively treating well-established dementia, such as Alzheimer’s disease (AD), are slim, due to the destruction of key brain pathways that underlie higher cognitive function. There has been a substantial shift in the field towards detecting conditions such as AD in their earlies...
Autores principales: | Vickers, James C., Mitew, Stan, Woodhouse, Adele, Fernandez-Martos, Carmen M., Kirkcaldie, Mathew T., Canty, Alison J., McCormack, Graeme H., King, Anna E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4917817/ https://www.ncbi.nlm.nih.gov/pubmed/26679855 http://dx.doi.org/10.2174/1567205013666151218150322 |
Ejemplares similares
-
Neurites containing the neurofilament-triplet proteins are selectively vulnerable to cytoskeletal pathology in Alzheimer’s disease and transgenic mouse models
por: Mitew, Stanislaw, et al.
Publicado: (2013) -
Environmental novelty exacerbates stress hormones and Aβ pathology in an Alzheimer’s model
por: Stuart, Kimberley E., et al.
Publicado: (2017) -
Age, but Not Amyloidosis, Induced Changes in Global Levels of Histone Modifications in Susceptible and Disease-Resistant Neurons in Alzheimer’s Disease Model Mice
por: Dyer, Marcus, et al.
Publicado: (2019) -
Plasma Amyloid as Prescreener for the Earliest Alzheimer Pathological Changes
por: Verberk, Inge M. W., et al.
Publicado: (2018) -
Repeat propofol anesthesia does not exacerbate plaque deposition or synapse loss in APP/PS1 Alzheimer’s disease mice
por: Woodhouse, Adele, et al.
Publicado: (2018)